Pomdoctor Ltd ADR(POM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | 7.0M | Perf Week | 5.87% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -15.9% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | 0.39% | Short Float | - | Perf Quarter | -42.52% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | -10.9% | Short Ratio | 0.28 | Perf Half Y | -86.82% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.02M | Perf YTD | -84.95% |
| Book/sh | - | P/C | - | EPS past 3/5Y | -47.9% -10.17% | ROE | - | 52W High | -99.31% ($115.74) | Perf Year | - |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | 15.17% 22.15% | ROIC | - | 52W Low | 59.8% ($0.50) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 14.36% 12.19% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.11 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 44.44 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -4.34% ($0.84) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | 2026/5/14 | SMA50 | -9.27% ($0.88) | Rel Volume | 0.11 | Prev Close | $0.8 |
| Employees | 165 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -85.22% ($5.41) | Avg Volume(3M) | 0.07M | Price | $0.8 |
| IPO | 2025/10/8 | Option/Short | No/Yes | Trades | 56 | Volume | 7,432 | Change | -0.12% |
Company
POM is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 It's a Chinese online healthcare platform specializing in chronic disease management. It operates two businesses: internet hospitals (teleconsultations and e-prescriptions) and a pharmaceutical supply chain (retail and wholesale pharmacy). It connects patients, doctors, and medications in a one-stop service. Headquartered in Guangzhou, the company listed on Nasdaq as an ADR in 2025.
Over the past 1 year, on the lower side
99% below its 1-year high.
The price looks about right
Trading at - times earnings.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 0.4%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $5M.
POM $5M PER -
HITI $246M PER -
PETS $34M PER -
SCNX $12M PER -
FAQ
What kind of company is POM?
POM belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.
What is the market cap of POM?
The market cap of POM is approximately $5M, ranking 5,675 within its sector.
What is the 52-week high and low for POM?
POM has recorded a 52-week high of $115.74 and a low of $0.50.
